[HTML][HTML] Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018

MAW Dinnessen, O Visser, SH Tonino… - Blood Cancer …, 2021 - nature.com
The improved longevity of patients with follicular lymphoma (FL) is offset by an increased
risk of a variety of second primary malignancies (SPMs) compared to the general population …

Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in The Netherlands …

K Amaador, MJ Kersten, O Visser… - British journal of …, 2022 - Wiley Online Library
It is unclear how treatment advances impacted the population‐level survival of patients with
lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia (LPL/WM). Therefore, we …

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre-and post-rituximab era

MAW Dinnessen, CCHM Maas, SH Tonino, O Visser… - Leukemia, 2022 - nature.com
The introduction of anti-CD20 antibodies has improved the population-level survival of
patients with follicular lymphoma (FL)[1, 2]. Nevertheless, specific subgroups still carry a …

[HTML][HTML] Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study

N Yu, W Zhang, X Zhong, X Song, W Li - Plos one, 2024 - journals.plos.org
Background The aim of this study was to investigate patient survival and factors associated
with survival in second primary non-Hodgkin lymphoma (NHL) compared with the first …

Late excess mortality in essential thrombocythemia: a population-based study in the Netherlands, 2001–2018

TSM Posthuma, O Visser, PAW Te Boekhorst… - Leukemia, 2022 - nature.com
Essential thrombocythemia (ET) is a clonal myeloproliferative neoplasm characterized by
excessive production of platelets—with occasionally elevated white blood cell counts …